Post sphinterotomy-bleeding (PSB) occurs in 1-2 % of Endosocpic Retrograde Cholangiopancreaticography (ERCP) and usually needs no blood transfusion after endoscopic therapy but can be life-threatening in some rare cases.~The increasing use of antiplatelet and/or anticoagulant therapies enhances the risk of PSB.~There are no prospective comparative studies concerning the endoscopic treatment of PSB due to the rarity of the incident.~Insertion of an endoprosthesis in the common bile duct may be more effective than Epinephrin-injection into the papilla which is the therapy of first choice.~A retrospective single centre analysis on both used methods over a study period of 16 years shall be performed.~In detail, clinical success and safety of the procedure, re-bleeding rate, number of re-interventions and days of hospital stay will be analysed.
Post sphinterotomy-bleeding (PSB) occurs in 1-2 % of Endosocpic Retrograde Cholangiopancreaticography (ERCP) and usually needs no blood transfusion after endoscopic therapy but can be life-threatening in some rare cases.~There are no prospective comparative studies concerning the endoscopic treatment of PSB due to the rarity of the incident.~Insertion of an endoprosthesis in the common bile duct may be more effective than Epinephrin-injection into the papilla which is the therapy of first choice.~A retrospective single centre analysis on both used methods over a study period of 16 years shall be performed.